These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2138 related items for PubMed ID: 16096179
1. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K. J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [Abstract] [Full Text] [Related]
5. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. Luger TA, Lahfa M, Fölster-Holst R, Gulliver WP, Allen R, Molloy S, Barbier N, Paul C, Bos JD. J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150 [Abstract] [Full Text] [Related]
13. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Hebert AA. Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454 [Abstract] [Full Text] [Related]
14. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. Fleischer AB, Abramovits W, Breneman D, Jaracz E, US/Canada tacrolimus ointment study group. J Dermatolog Treat; 2007 Dec; 18(3):151-7. PubMed ID: 17538803 [Abstract] [Full Text] [Related]
15. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351 [Abstract] [Full Text] [Related]
16. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US Tacrolimus Ointment Study Group. Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [Abstract] [Full Text] [Related]
17. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. Leung DY, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM, Abrams B, Hultsch T. Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245 [Abstract] [Full Text] [Related]
18. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Yan AC, Honig PJ, Ming ME, Weber J, Shah KN. Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693 [Abstract] [Full Text] [Related]
19. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis. Sigurgeirsson B, Ho V, Ferrándiz C, Andriano K, Grinienko A, Jimenez P, Pimecrolimus 1% cream in (paediatric) Eczema: Prevention of Progression multi-centre investigator study group. J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866 [Abstract] [Full Text] [Related]
20. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Gollnick H, Kaufmann R, Stough D, Heikkila H, Andriano K, Grinienko A, Jimenez P, Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group. Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]